Effect of Cystone® on urinary composition and stone formation over a one year period

Phytomedicine

Volumn 18, Issue 10, 2011, Pages 863-867

  Erickson, S B ^a   Vrtiska, T J ^a   Lieske, J C ^a  

^a MAYO CLINIC   (United States)

Author keywords

Computerized tomography; Cystone ; Herb; Kidney calculi; Nephrolithiasis; Quantitative CT; Supersaturation

Indexed keywords

ANTIUROLITHIASIS AGENT; CYSTONE; PLACEBO; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CALCIUM OXALATE STONE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; MALE; NEPHROLITHIASIS; OPEN STUDY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; URINALYSIS;

ADULT; AGED; CALCIUM OXALATE; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; KIDNEY CALCULI; MALE; MIDDLE AGED; PLACEBOS; PLANT EXTRACTS; PRODUCT SURVEILLANCE, POSTMARKETING; TREATMENT OUTCOME; URINE;

EID: 79959921159     PISSN: 09447113     EISSN: 1618095X     Source Type: Journal    
DOI: 10.1016/j.phymed.2011.01.018     Document Type: Article

References (21)

1. F. Atmani, Y. Slimani, M. Mimouni, M. Aziz, B. Hacht, and A. Ziyyat Effect of aqueous extract from Herniaria hirsuta L. on experimentally nephrolithiasic rats J. Ethnopharmacol. 95 2004 87 93 (Pubitemid 39221416)
2. J.B. Calixto, A.R. Santos, V. Cechinel Filho, and R.A. Yunes A review of the plants of the genus Phyllanthus: their chemistry, pharmacology, and therapeutic potential Med. Res. Rev. 18 1998 225 258 (Pubitemid 28346388)
3. J.B. Calixto, R.A. Yunes, A.S. Neto, R.M. Valle, and G.A. Rae Antispasmodic effects of an alkaloid extracted from Phyllanthus sellowianus: a comparative study with papaverine Braz. J. Med. Biol. Res. 17 1984 313 321 (Pubitemid 15217466)
4. A.H. Campos, and N. Schor Phyllanthus niruri inhibits calcium oxalate endocytosis by renal tubular cells: its role in urolithiasis Nephron 81 1999 393 397 (Pubitemid 29150122)
5. B. Ettinger, J.T. Citron, B. Livermore, and L.I. Dolman Chlorthalidone reduces calcium oxalate calculous recurrence but magnesium hydroxide does not J. Urol. 139 1988 679 684
6. B. Ettinger, C.Y. Pak, J.T. Citron, C. Thomas, B. Adams-Huet, and A. Vangessel Potassium-magnesium citrate is an effective prophylaxis against recurrent calcium oxalate nephrolithiasis J. Urol. 158 1997 2069 2073 (Pubitemid 27481329)
7. B. Ettinger, A. Tang, J.T. Citron, B. Livermore, and T. Williams Randomized trial of allopurinol in the prevention of calcium oxalate calculi N. Engl. J. Med. 315 1986 1386 1389 (Pubitemid 17055411)
8. D.S. Goldfarb Increasing prevalence of kidney stones in the United States Kidney Int. 63 2003 1951 1952 (Pubitemid 36513347)
9. F. Grases, J.G. March, R.M. Prieto, B.M. Simonet, A. Costa-Bauza, A. Garcia-Raja, and A. Conte Urinary phytate in calcium oxalate stone formers and healthy people Scand. J. Urol. Nephrol. 34 2000 162 164
10. J.M. Hollingsworth, M.A.M. Rogers, S.R. Kaufman, T.J. Bradford, S. Saint, J.T. Wei, and B.K. Hollenbeck Medical therapy to facilitate urinary stone passage: a meta-analysis Lancet 368 2006 1171 1179 (Pubitemid 44441578)
11. T. Koide, S. Yamaguchi, M. Utsunomiya, T. Yoshioka, and K. Sugiyama The inhibitory effect of Kampou extracts on in vitro calcium oxalate crystallization and in vivo stone formation in an animal model Int. J. Urol. 2 1995 81 86
12. V. Kumar, L. Pena de la Vega, G. Farell, and J.C. Lieske Urinary macromolecular inhibition of crystal adhesion to renal epithelial cells is impaired in male stone formers Kidney Int. 68 2005 1784 1792 (Pubitemid 43169923)
13. J.L. Nishiura, A.H. Campos, M.A. Boim, I.P. Heilberg, and N. Schor Phyllanthus niruri normalizes elevated urinary calcium levels in calcium stone forming (CSF) patients Urol. Res. 32 2004 362 366 (Pubitemid 39517961)
14. J.H. Parks, M. Coward, and F.L. Coe Correspondence between stone composition and urine supersaturation in nephrolithiasis Kidney Int. 51 1997 894 900 (Pubitemid 27157979)
15. A. Rodgers, S. Allie-Hamdulay, and G. Jackson Therapeutic action of citrate in urolithiasis explained by chemical speciation: increase in pH is the determinant factor Nephrol. Dial. Transplant. 21 2006 361 369 (Pubitemid 43159989)
16. C.S. Saigal, G. Joyce, and A.R. Timilsina Direct and indirect costs of nephrolithiasis in an employed population: opportunity for disease management? Kidney Int. 68 2005 1808 1814 (Pubitemid 43169926)
17. A.R. Santos, V.C. Filho, R. Niero, A.M. Viana, F.N. Moreno, M.M. Campos, R.A. Yunes, and J.B. Calixto Analgesic effects of callus culture extracts from selected species of Phyllanthus in mice J. Pharm. Pharmacol. 46 1994 755 759 (Pubitemid 24289666)
18. M.R. Sowers, M. Jannausch, C. Wood, S.K. Pope, L.L. Lachance, and B. Peterson Prevalence of renal stones in a population-based study with dietary calcium, oxalate, and medication exposures Am. J. Epidemiol. 147 1998 914 920 (Pubitemid 28244162)
19. K.K. Stamatelou, M.E. Francis, C.A. Jones, L.M. Nyberg, and G.C. Curhan Time trends in reported prevalence of kidney stones in the United States: 1976-1994 Kidney Int. 63 2003 1817 1823 (Pubitemid 36513328)
20. P.J. Werness, C.M. Brown, L.H. Smith, and B. Finlayson EQUIL2: a BASIC computer program for the calculation of urinary saturation J. Urol. 134 1985 1242 1244 (Pubitemid 16207045)
21. T. Yasui, K. Fujita, M. Sato, M. Sugimoto, M. Iguchi, S. Nomura, and K. Kohri The effect of Takusya, a Kampou medicine, on renal stone formation and osteopontin expression in rat urolithiasis model Urol. Res. 27 1999 194 199 (Pubitemid 29287598)